Teva Pharmaceutical Industries Ltd. announced that the FDA has on 28 March 2013, approved Quartette, (levonorgestrel/ethinyl estradiol and ethinyl estradiol)...
Agile Therapeutics has made a new drug application for its once-weekly, low-dose contraceptive patch, AG200-15,(ethinyl estradiol plus levonorgestrel) and the...
Teva Women�s Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd, has announced that the FDA has accepted for...